High-Dose Carmustine, Etoposide, and Cyclophosphamide Followed by Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

This publication has 40 references indexed in Scilit:

• Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry
  Blood, 2004
• Lymphoma rate rise continues to baffle researchers.
  JNCI Journal of the National Cancer Institute, 2001
• ADULT ACUTE LYMPHOCYTIC LEUKEMIA STUDY TESTING CHEMOTHERAPY AND AUTOLOGOUS AND ALLOGENEIC TRANSPLANTATION: A Follow-Up Report of the French Protocol LALA 87
  Hematology/Oncology Clinics of North America, 2000
• Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database
  British Journal of Haematology, 1999
• Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma: Updated Results of the Utrecht Experience
  Leukemia & Lymphoma, 1999
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995
• Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia
  New England Journal of Medicine, 1995
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique
  Blood, 1992
• Detection of Minimal Residual Cells Carrying the t(14;18) by DNA Sequence Amplification
  Science, 1987